Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Clinical and Molecular Comparative Analysis of KRAS Exon 2 and KRAS Non-Exon 2 Mutated Colorectal Cancer.

Cancers·2026
Same author

Immune Checkpoint Inhibitor Outcomes Across Child-Pugh A, B, and C Hepatocellular Carcinoma: A Real-World Integrated Health-System Cohort.

Cancer treatment and research communications·2026
Same author

EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual disease.

Future oncology (London, England)·2026
Same author

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma.

Journal of hepatology·2026
Same author

Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive niche.

Cancer letters·2026
Same author

Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC).

The oncologist·2026

相关实验视频

Updated: May 28, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K

收养T细胞治疗向MAGE-A4的目标

Kapil Chandora1, Akshay Chandora1, Anwaar Saeed2

  • 1Morehouse School of Medicine, 720 Westview Dr, Atlanta, GA 30310, USA.

Cancers
|February 13, 2025
PubMed
概括

黑色素瘤抗原基因A4 (MAGE A4) 是一种癌症丸抗原,在瘤中发现,但不是正常细胞. 这篇评论探讨了MAGE A4的研究.

关键词:
在MAGE-A4中使用.收养的T细胞疗法抗体是一种抗体.癌症 丸 抗原 抗原这是食道癌症.免疫疗法 免疫疗法卵巢癌是发生在卵巢的癌症.肉瘤 肉瘤是一种肉瘤.固体瘤是一种固体瘤.

更多相关视频

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.8K

相关实验视频

Last Updated: May 28, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.5K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

7.8K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 遗传学 是一个遗传学.

背景情况:

  • 黑色素瘤抗原基因A4 (MAGE A4) 是一种癌症丸抗原 (CTA).
  • MAGE A4通常在生殖细胞中表达,但不在体细胞中.
  • MAGE A4在各种癌症中得到表达,包括突肉瘤,卵巢癌和非小细胞肺癌.

研究的目的:

  • 审查MAGE A4的功能和表达模式.
  • 总结目前针对免疫治疗的MAGE A4的临床试验.
  • 讨论MAGE A4向治疗的挑战和机遇.

主要方法:

  • 科学出版物和临床试验数据的文献综述.
  • 在不同类型的瘤中分析MAGE A4表达特征.
  • 针对MAGE A4的免疫治疗策略的评估.

主要成果:

  • MAGE A4的受限表达使其成为癌症免疫治疗的有希望的目标.
  • 几项临床试验正在研究MAGE A4向疗法.
  • 了解MAGE A4的作用对于开发有效的治疗方法至关重要.

结论:

  • MAGE A4代表了开发新型癌症免疫疗法的重要目标.
  • 需要进一步的研究和临床试验来克服治疗挑战.
  • 向的MAGE A4疗法具有治疗特定恶性瘤的潜力.